Literature DB >> 2501250

Gene expression of terminal deoxynucleotidyl transferase in neoplastic cells of leukemia and lymphoma.

K Oiwa1, O Koiwai, T Kaneda.   

Abstract

Expression levels of terminal deoxynucleotidyl transferase (TdT) mRNA in fresh leukemia and lymphoma cells were measured by northern blotting analysis. Bands of 2.1 kb mRNA were detected in all of eight cases of TdT activity-positive leukemias: two cases of null-cell acute lymphoblastic leukemia (null-ALL), two of common ALL, one of pre-B ALL, one of T-ALL, and two of chronic myelogenous leukemia in blastic crisis. One of the null-ALL and one of the common ALL cases also showed large TdT mRNA (3.3 kb). Since all TdT activity-positive samples exhibited TdT mRNA, the TdT gene might be mainly regulated at the transcription level in leukemic cells. An elevated level of 2.1 kb TdT mRNA was also detected in one lymphoma case, where neither TdT activity nor immunoreactive TdT was detected. The extensive chromosomal abnormality demonstrated in this case might be associated with the translational anomaly of TdT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501250      PMCID: PMC5917742          DOI: 10.1111/j.1349-7006.1989.tb02315.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


terminal deoxynucleotidyl transferase acute lymphoblastic leukemia acute myelogenous leukemia chronic myelogenous leukemia in blastic crisis
  19 in total

1.  Oligodeoxyribonucleotide-primed reactions catalyzed by calf thymus polymerase.

Authors:  F J BOLLUM
Journal:  J Biol Chem       Date:  1962-06       Impact factor: 5.157

2.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

3.  Highly sensitive solid-phase enzyme immunoassay for terminal deoxynucleotidyl transferase.

Authors:  T Kaneda; S Kuroda; Y Hirota; K Kato
Journal:  Anal Biochem       Date:  1982-11-01       Impact factor: 3.365

4.  Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector.

Authors:  N R Landau; D G Schatz; M Rosa; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

5.  Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia.

Authors:  G Janossy; F J Bollum; K F Bradstock; A McMichael; N Rapson; M F Greaves
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Molecular cloning of human terminal deoxynucleotidyltransferase.

Authors:  R C Peterson; L C Cheung; R J Mattaliano; L M Chang; F J Bollum
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Measurement of terminal deoxynucleotidyl transferase mRNA in clinical samples: a new parameter in analysis of leukemia cells.

Authors:  S C Wolf; P G Steinherz; N R Landau; A E Silverstone
Journal:  Am J Hematol       Date:  1987-07       Impact factor: 10.047

8.  Terminal deoxynucleotidyl transferase expression can precede T cell receptor beta chain and gamma chain rearrangement in T cell acute lymphoblastic leukemia.

Authors:  J M Greenberg; J H Kersey
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

9.  Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.

Authors:  R McCaffrey; T A Harrison; R Parkman; D Baltimore
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

10.  Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.

Authors:  R Foa; G Casorati; M C Giubellino; G Basso; R Schirò; G Pizzolo; F Lauria; M P Lefranc; T H Rabbitts; N Migone
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.